Cargando…

Replication Fork Stability Confers Chemoresistance in BRCA-deficient Cells

Brca1- and Brca2-deficient cells have reduced capacity to repair DNA double-strand breaks (DSBs) by homologous recombination (HR) and consequently are hypersensitive to DNA damaging agents, including cisplatin and poly(ADP-ribose) polymerase (PARP) inhibitors. Here we show that loss of the MLL3/4 co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhuri, Arnab Ray, Callen, Elsa, Ding, Xia, Gogola, Ewa, Duarte, Alexandra A., Lee, Ji-Eun, Wong, Nancy, Lafarga, Vanessa, Calvo, Jennifer A., Panzarino, Nicholas J., John, Sam, Day, Amanda, Crespo, Anna Vidal, Shen, Binghui, Starnes, Linda M., de Ruiter, Julian R., Daniel, Jeremy A., Konstantinopoulos, Panagiotis A., Cortez, David, Cantor, Sharon B., Fernandez-Capetillo, Oscar, Ge, Kai, Jonkers, Jos, Rottenberg, Sven, Sharan, Shyam K., Nussenzweig, André
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959813/ https://www.ncbi.nlm.nih.gov/pubmed/27443740 http://dx.doi.org/10.1038/nature18325

Ejemplares similares

Replication fork reversal triggers fork degradation in BRCA2-defective cells
por: Mijic, Sofija, et al.
Publicado: (2017)

Thwarting endogenous stress: BRCA protects against aldehyde toxicity
por: Ray Chaudhuri, Arnab, et al.
Publicado: (2017)

Interferon restores replication fork stability and cell viability in BRCA-defective cells via ISG15
por: Moro, Ramona N., et al.
Publicado: (2023)

Loss of MED12 activates the TGFβ pathway to promote chemoresistance and replication fork stability in BRCA-deficient cells
por: Jackson, Lindsey M, et al.
Publicado: (2021)

Opposing Roles of FANCJ and HLTF Protect Forks and Restrain Replication during Stress
por: Peng, Min, et al.
Publicado: (2018)

WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells
por: Datta, Arindam, et al.
Publicado: (2021)

A protective role for BRCA2 at stalled replication forks
por: Chandramouly, Gurushankar, et al.
Publicado: (2011)

Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors
por: Bhin, Jinhyuk, et al.
Publicado: (2023)

Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
por: Ding, Xia, et al.
Publicado: (2016)

Two replication fork remodeling pathways generate nuclease substrates for distinct fork protection factors
por: Liu, W., et al.
Publicado: (2020)

Fork Protection and Therapy Resistance in Hereditary Breast Cancer
por: Cantor, Sharon B., et al.
Publicado: (2018)

Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4
por: Guillemette, Shawna, et al.
Publicado: (2015)

ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
por: Yazinski, Stephanie A., et al.
Publicado: (2017)

Efficacy of ATR inhibitors as single agents in Ewing sarcoma
por: Nieto-Soler, Maria, et al.
Publicado: (2016)

Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers
por: Liptay, Martin, et al.
Publicado: (2020)

USP7 and VCP(FAF1) define the SUMO/Ubiquitin landscape at the DNA replication fork
por: Franz, André, et al.
Publicado: (2021)

Cockayne syndrome group B protein regulates fork restart, fork progression and MRE11-dependent fork degradation in BRCA1/2-deficient cells
por: Batenburg, Nicole L, et al.
Publicado: (2021)

BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks
por: Willis, Nicholas A., et al.
Publicado: (2014)

EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors
por: Zander, Serge A. L., et al.
Publicado: (2012)

SMARCAD1-mediated active replication fork stability maintains genome integrity
por: Lo, Calvin Shun Yu, et al.
Publicado: (2021)

EXD2 Protects Stressed Replication Forks and Is Required for Cell Viability in the Absence of BRCA1/2
por: Nieminuszczy, Jadwiga, et al.
Publicado: (2019)

MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells
por: Lemaçon, Delphine, et al.
Publicado: (2017)

TPX2 joins 53BP1 to maintain DNA repair and fork stability
por: Cantor, Sharon
Publicado: (2019)

PRIMPOL-Mediated Adaptive Response Suppresses Replication Fork Reversal in BRCA-Deficient Cells
por: Quinet, Annabel, et al.
Publicado: (2020)

The TIP60-ATM axis regulates replication fork stability in BRCA-deficient cells
por: Schleicher, Emily M., et al.
Publicado: (2022)

Fork reversal, too much of a good thing
por: Couch, Frank B, et al.
Publicado: (2014)

Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links
por: Rickman, Kimberly A., et al.
Publicado: (2020)

RIF1 promotes replication fork protection and efficient restart to maintain genome stability
por: Mukherjee, Chirantani, et al.
Publicado: (2019)

PDS5 proteins are required for proper cohesin dynamics and participate in replication fork protection
por: Morales, Carmen, et al.
Publicado: (2020)

MEK inhibition as a strategy for targeting residual breast cancer cells with low DUSP4 expression
por: Rottenberg, Sven, et al.
Publicado: (2012)

The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells
por: Barazas, Marco, et al.
Publicado: (2018)

Homologous Recombination as a Replication Fork Escort: Fork-Protection and Recovery
por: Costes, Audrey, et al.
Publicado: (2012)

The linker histone H1–BRCA1 axis is a crucial mediator of replication fork stability
por: Ozgencil, Meryem, et al.
Publicado: (2023)

XRCC1 promotes replication restart, nascent fork degradation and mutagenic DNA repair in BRCA2-deficient cells
por: Eckelmann, Bradley J, et al.
Publicado: (2020)

NF-κB is a Critical Mediator of BRCA1 induced Chemoresistance
por: Harte, Mary T, et al.
Publicado: (2013)

BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer
por: Nakashima, Shinsuke, et al.
Publicado: (2015)

Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells
por: Schoonen, Pepijn M., et al.
Publicado: (2017)

Preclinical mouse models for BRCA1-associated breast cancer
por: Drost, R M, et al.
Publicado: (2009)

Oligomerization of DNA replication regulatory protein RADX is essential to maintain replication fork stability
por: Mohamed, Taha, et al.
Publicado: (2022)

CtIP-BRCA1 complex and MRE11 maintain replication forks in the presence of chain terminating nucleoside analogs
por: Mohiuddin, Mohiuddin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dvcm7nhvaac4uc4laftgka251u